Syngene collaborates with Johns Hopkins University to advance early-stage drug discovery
The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
The collaboration is anchored in Syngene’s SynVent platform and Connector model to accelerate promising academic research
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
Company to launch product after the expiry of semaglutide patent in India
A dedicated Life Sciences Innovation Fund, scalable up to Rs. 1,000 crore, will catalyze early- and growth-stage innovation, support deep-tech ventures – particularly biotherapeutics
Backed by two CAP - accredited genomics labs in Delhi NCR and Mumbai, supporting oncology, reproductive health, neurology, transplant immunology, and rare diseases
The multimillion-dollar facility combines discovery and early-phase scale-up capabilities with R&D labs and two pilot plants
Rajdeep is an accomplished business leader with a strong techno-commercial background in the healthcare and diagnostic sector
Subscribe To Our Newsletter & Stay Updated